Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 324

1.

A renal risk score for ANCA-associated glomerulonephritis.

Wester Trejo MAC, van Daalen EE, Berden AE, Wolterbeek R, van Es LA, Bos WJW, Ferrario F, Hagen EC, Jennette JC, Joh K, Neumann I, Noël LH, Pusey CD, Bruijn JA, Bajema IM.

Kidney Int. 2019 Jul;96(1):245. doi: 10.1016/j.kint.2019.01.046. No abstract available.

PMID:
31229031
2.

Complement-mediated microangiopathy in IgA nephropathy and IgA vasculitis with nephritis.

Chua JS, Zandbergen M, Wolterbeek R, Baelde HJ, van Es LA, de Fijter JW, Bruijn JA, Bajema IM.

Mod Pathol. 2019 Jul;32(8):1147-1157. doi: 10.1038/s41379-019-0259-z. Epub 2019 Apr 1.

PMID:
30936425
3.

Apolipoprotein C-I plays a role in the pathogenesis of glomerulosclerosis.

Bus P, Pierneef L, Bor R, Wolterbeek R, van Es LA, Rensen PC, de Heer E, Havekes LM, Bruijn JA, Berbée JF, Baelde HJ.

J Pathol. 2017 Apr;241(5):589-599. doi: 10.1002/path.4859. Epub 2017 Feb 2.

PMID:
27976371
4.

Moh Daha, a successful scientist with a strong personality, who loves to stimulate and support his colleagues.

van Es LA.

Mol Immunol. 2015 Nov;68(1):2-5. doi: 10.1016/j.molimm.2015.06.007. Review.

PMID:
26597198
5.

Complement Factor C4d Is a Common Denominator in Thrombotic Microangiopathy.

Chua JS, Baelde HJ, Zandbergen M, Wilhelmus S, van Es LA, de Fijter JW, Bruijn JA, Bajema IM, Cohen D.

J Am Soc Nephrol. 2015 Sep;26(9):2239-47. doi: 10.1681/ASN.2014050429. Epub 2015 Jan 8.

6.

Genetic associations in diabetic nephropathy: a meta-analysis.

Mooyaart AL, Valk EJ, van Es LA, Bruijn JA, de Heer E, Freedman BI, Dekkers OM, Baelde HJ.

Diabetologia. 2011 Mar;54(3):544-53. doi: 10.1007/s00125-010-1996-1. Epub 2010 Dec 3. Erratum in: Diabetologia. 2014 Mar;57(3):650.

7.

GMP-17-positive T-lymphocytes in renal tubules predict progression in early stages of IgA nephropathy.

van Es LA, de Heer E, Vleming LJ, van der Wal A, Mallat M, Bajema I, Bruijn JA, de Fijter JW.

Kidney Int. 2008 Jun;73(12):1426-33. doi: 10.1038/ki.2008.66. Epub 2008 Mar 19.

8.

South-Asian type 2 diabetic patients have higher incidence and faster progression of renal disease compared with Dutch-European diabetic patients.

Chandie Shaw PK, Baboe F, van Es LA, van der Vijver JC, van de Ree MA, de Jonge N, Rabelink TJ.

Diabetes Care. 2006 Jun;29(6):1383-5. No abstract available.

PMID:
16732026
9.

The absence of delayed graft function is predicted by the presence of manganese-superoxide dismutase in distal tubules of renal allografts.

Boom H, de Heer E, van der Wal A, Kruidenier L, de Fijter JW, Benediktsson H, Paul LC, van Es LA.

Transplantation. 2005 Apr 27;79(8):946-52.

PMID:
15849548
10.

Calcium levels as a risk factor for delayed graft function.

Boom H, Mallat MJ, de Fijter JW, Paul LC, Bruijn JA, van Es LA.

Transplantation. 2004 Mar 27;77(6):868-73.

PMID:
15077029
11.

No effect of enalapril on progression in autosomal dominant polycystic kidney disease.

van Dijk MA, Breuning MH, Duiser R, van Es LA, Westendorp RG.

Nephrol Dial Transplant. 2003 Nov;18(11):2314-20.

PMID:
14551359
12.

Renal disease in relatives of Indo-Asian Type 2 diabetic patients with end-stage diabetic nephropathy.

Chandie Shaw PK, van Es LA, Paul LC, Rosendaal FR, Souverijn JH, Vandenbroucke JP.

Diabetologia. 2003 May;46(5):618-24. Epub 2003 May 9.

PMID:
12739019
13.

Complexes of IgA with FcalphaRI/CD89 are not specific for primary IgA nephropathy.

van der Boog PJ, De Fijter JW, Van Kooten C, Van Der Holst R, Van Seggelen A, Van Es LA, Daha MR.

Kidney Int. 2003 Feb;63(2):514-21.

14.

Increased end-stage diabetic nephropathy in Indo-Asian immigrants living in the Netherlands.

Chandie Shaw PK, Vandenbroucke JP, Tjandra YI, Rosendaal FR, Rosman JB, Geerlings W, de Charro FT, van Es LA.

Diabetologia. 2002 Mar;45(3):337-41.

PMID:
11914738
15.

Risk factors of cyclosporine nephrotoxicity after conversion from Sandimmune to Neoral.

Sijpkens YW, Mallat MJ, Siegert CE, Zwinderman AH, Westendorp RG, de Fijter JW, van Es LA, Paul LC.

Clin Nephrol. 2001 Feb;55(2):149-55.

PMID:
11269679
16.

Surrogate markers of chronic allograft nephropathy.

van Es LA, Sijpkens YW, Paul LC.

Ann Transplant. 2000;5(2):7-11. Review. No abstract available.

PMID:
11217210
17.

Endothelial cell chimerism after renal transplantation and vascular rejection.

Lagaaij EL, Cramer-Knijnenburg GF, van Kemenade FJ, van Es LA, Bruijn JA, van Krieken JH.

Lancet. 2001 Jan 6;357(9249):33-7.

PMID:
11197359
18.

Morphometry of interstitial fibrosis.

De Heer E, Sijpkens YW, Verkade M, den Dulk M, Langers A, Schutrups J, Bruijn JA, van Es LA.

Nephrol Dial Transplant. 2000;15 Suppl 6:72-3. Review.

PMID:
11143998
19.

Sharing cross-reactive groups of MHC class I improves long-term graft survival.

Sijpkens YW, Doxiadis II, De Fijter JW, Mallat MJ, van Es LA, De Lange P, Zwinderman AH, Westendorp RG, van Kemenade FJ, Bruijn JA, Claas FH, Paul LC.

Kidney Int. 1999 Nov;56(5):1920-7.

20.

Tubular epithelial cells: A critical cell type in the regulation of renal inflammatory processes.

van Kooten C, Daha MR, van Es LA.

Exp Nephrol. 1999 Sep-Dec;7(5-6):429-37. Review.

PMID:
10559641
21.

Sequential development of anti-GBM nephritis and ANCA-associated Pauci-immune glomerulonephritis.

Verburgh CA, Bruijn JA, Daha MR, van Es LA.

Am J Kidney Dis. 1999 Aug;34(2):344-8.

PMID:
10430985
22.

Synergistic effect of interleukin-1 and CD40L on the activation of human renal tubular epithelial cells.

van Kooten C, van der Linde X, Woltman AM, van Es LA, Daha MR.

Kidney Int. 1999 Jul;56(1):41-51.

23.

Recurrence of IgA nephropathy after renal transplantation.

van der Boog PJ, de Fijter JW, Bruijn JA, van Es LA.

Ann Med Interne (Paris). 1999 Feb;150(2):137-42. Review.

PMID:
10392262
24.

Effect of danaparoid sodium on proteinuria, von Willebrand factor, and hard exudates in patients with diabetes mellitus type 2.

van der Pijl JW, Lemkes HH, Frölich M, van der Woude FJ, van der Meer FJ, Van Es LA.

J Am Soc Nephrol. 1999 Jun;10(6):1331-6.

25.

The terminal sequence of complement plays an essential role in antibody-mediated renal cell apoptosis.

Sato T, Van Dixhoorn MG, Prins FA, Mooney A, Verhagen N, Muizert Y, Savill J, Van Es LA, Daha MR.

J Am Soc Nephrol. 1999 Jun;10(6):1242-52.

26.

The pathogenesis of progressive renal failure.

Vleming LJ, Bruijn JA, van Es LA.

Neth J Med. 1999 Mar;54(3):114-28. Review.

PMID:
10189786
27.

The DD genotype of the ACE gene polymorphism is associated with progression of diabetic nephropathy to end stage renal failure in IDDM.

Vleming LJ, van der Pijl JW, Lemkes HH, Westendorp RG, Maassen JA, Daha MR, van Es LA, van Kooten C.

Clin Nephrol. 1999 Mar;51(3):133-40.

PMID:
10099885
28.

Decreased IgA1 response after primary oral immunization with live typhoid vaccine in primary IgA nephropathy.

Roodnat JI, de Fijter JW, van Kooten C, Daha MR, van Es LA.

Nephrol Dial Transplant. 1999 Feb;14(2):353-9.

PMID:
10069188
29.

Interleukin-17 activates human renal epithelial cells in vitro and is expressed during renal allograft rejection.

Van Kooten C, Boonstra JG, Paape ME, Fossiez F, Banchereau J, Lebecque S, Bruijn JA, De Fijter JW, Van Es LA, Daha MR.

J Am Soc Nephrol. 1998 Aug;9(8):1526-34.

30.

Histomorphometric correlates of renal failure in IgA nephropathy.

Vleming LJ, de Fijter JW, Westendorp RG, Daha MR, Bruijn JA, van Es LA.

Clin Nephrol. 1998 Jun;49(6):337-44.

PMID:
9696428
31.

Extracellular matrix in human diabetic nephropathy: reduced expression of heparan sulphate in skin basement membrane.

van der Pijl JW, Daha MR, van den Born J, Verhagen NA, Lemkes HH, Bucala R, Berden JH, Zwinderman AH, Bruijn JA, van Es LA, van der Woude FJ.

Diabetologia. 1998 Jul;41(7):791-8.

PMID:
9686920
32.

[Immunology in medical practice. IV. Mechanisms in the development of primary nephropathies].

Siegert CE, Weening JJ, van Es LA, Daha MR.

Ned Tijdschr Geneeskd. 1998 Apr 4;142(14):759-67. Review. Dutch. Erratum in: Ned Tijdschr Geneeskd 1998 May 16;142(20):1176.

PMID:
9646607
33.

Production of inflammatory mediators and cytokine responsiveness of an SV40-transformed human proximal tubular epithelial cell line.

Gerritsma JS, van Kooten C, Gerritsen AF, Mommaas AM, van Es LA, Daha MR.

Exp Nephrol. 1998 May-Jun;6(3):208-16.

PMID:
9639036
34.

Decreased cytokine-induced IgA subclass production by CD40-ligated circulating B cells in primary IgA nephropathy.

de Fijter JW, van Nisselrooij NI, Schroeijers WE, Daha MR, van Es LA, van Kooten C.

Nephrol Dial Transplant. 1998 Feb;13(2):285-92.

PMID:
9509436
35.

Transforming growth factor-beta 1 regulates chemokine and complement production by human proximal tubular epithelial cells.

Gerritsma JS, van Kooten C, Gerritsen AF, van Es LA, Daha MR.

Kidney Int. 1998 Mar;53(3):609-16.

36.

Increased IL-10 production by stimulated whole blood cultures in primary IgA nephropathy.

De Fijter JW, Daha MR, Schroeijers WE, van Es LA, Van Kooten C.

Clin Exp Immunol. 1998 Feb;111(2):429-34.

37.

Anti-C1q receptor/calreticulin autoantibodies in patients with systemic lupus erythematosus (SLE).

van den Berg RH, Siegert CE, Faber-Krol MC, Huizinga TW, van Es LA, Daha MR.

Clin Exp Immunol. 1998 Feb;111(2):359-64.

38.

Effect of danaparoid sodium on hard exudates in diabetic retinopathy.

van der Pijl JW, van der Woude FJ, Swart W, van Es LA, Lemkes HH.

Lancet. 1997 Dec 13;350(9093):1743-5.

PMID:
9413466
39.

Complement C6 and C2 biosynthesis in syngeneic PVG/c- and PVG/c+ rat strains.

Timmerman JJ, van Dixhoorn MG, Schraa EO, van Gijlswijk-Janssen DJ, Muizert Y, van Es LA, Daha MR.

Scand J Immunol. 1997 Oct;46(4):366-72.

40.

Differential effects of cytomegalovirus infection on complement synthesis by human mesangial cells.

Timmerman JJ, Beersma MF, van Gijlswijk-Janssen DJ, van Es LA, van der Woude FJ, Daha MR.

Clin Exp Immunol. 1997 Sep;109(3):518-25.

41.

C1q, a subunit of the first component of complement, enhances antibody-mediated apoptosis of cultured rat glomerular mesangial cells.

Sato T, van Dixhoorn MG, Heemskerk E, van Es LA, Daha MR.

Clin Exp Immunol. 1997 Sep;109(3):510-7.

42.

Expression of the IL-2 receptor on human renal proximal tubular epithelial cells.

Gerritsma JS, Gerritsen AF, van Kooten C, van Es LA, Daha MR.

J Am Soc Nephrol. 1997 Oct;8(10):1510-6.

43.

Patient survival after renal transplantation; more than 25 years follow-up.

Arend SM, Mallat MJ, Westendorp RJ, van der Woude FJ, van Es LA.

Nephrol Dial Transplant. 1997 Aug;12(8):1672-9.

PMID:
9269647
44.

Induction of mesangial interleukin-6 synthesis by apoptotic U937 cells and monocytes.

Heidenreich S, Sato T, Schmidt M, August C, Timmerman JJ, van Es LA, Daha MR.

Kidney Int. 1997 Aug;52(2):318-28.

45.

Antigen-antibody complexes enhance the production of complement component C3 by human mesangial cells.

Timmerman JJ, Van Gijlswijk-Janssen DJ, Van Der Kooij SW, Van Es LA, Daha MR.

J Am Soc Nephrol. 1997 Aug;8(8):1257-65.

46.

Renal disease in Waldenström's macroglobulinaemia.

Veltman GA, van Veen S, Kluin-Nelemans JC, Bruijn JA, van Es LA.

Nephrol Dial Transplant. 1997 Jun;12(6):1256-9. No abstract available.

PMID:
9198063
47.

Extrahepatic C6 is as effective as hepatic C6 in the generation of renal C5b-9 complexes.

Timmerman JJ, van Dixhoorn MG, Schraa EO, van Gijlswijk-Janssen DJ, Muizert Y, Van ES LA, Daha MR.

Kidney Int. 1997 Jun;51(6):1788-96.

48.

Pancreas and kidney allograft-infiltrating cells in simultaneous pancreas-kidney transplantation.

Boonstra JG, Deckers JG, Laterveer JC, Price V, van Es LA, Bruijn JA, Daha MR, van der Woude FJ.

Transplantation. 1997 May 27;63(10):1470-5.

PMID:
9175812
49.

Intracellular localization of the human receptor for the globular domains of C1q.

van den Berg RH, Prins F, Faber-Krol MC, Lynch NJ, Schwaeble W, van Es LA, Daha MR.

J Immunol. 1997 Apr 15;158(8):3909-16.

PMID:
9103461
50.

Interferon-gamma induces biosynthesis of complement components C2, C4 and factor H by human proximal tubular epithelial cells.

Gerritsma JS, Gerritsen AF, De Ley M, van Es LA, Daha MR.

Cytokine. 1997 Apr;9(4):276-83.

PMID:
9112336

Supplemental Content

Loading ...
Support Center